?
How should clinical trials stratify patients by underlying pathology rather than clinical syndrome alone?
active
open question
Created: 2026-04-25T20:26:27
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-56c73ed9-e5cd-4934-bb2e-fd
Open Question
open
Wiki: diseases-frontotemporal-lobar-degeneration
How should clinical trials stratify patients by underlying pathology rather than clinical syndrome alone?
Importance Elo
1500
Field Rank
Rank #159 in diseases
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page diseases-frontotemporal-lobar-degeneration
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:26:27.420813'} |
| field_tag | diseases |
| source_id | diseases-frontotemporal-lobar-degeneration |
| sub_field | frontotemporal-lobar-degeneration |
| source_kind | wiki |
| question_hash | c401899d7142a410a3d09b529c21405839aec8985362c833d4b1ffcd25a336c2 |
| question_text | How should clinical trials stratify patients by underlying pathology rather than clinical syndrome alone? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page diseases-frontotemporal-lobar-degeneration |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.